Literature DB >> 72824

Characterization of an antigen from the myelogenous leukemia cell line K-562.

J L Collins, C J Wust, B B Lozzio, C B Lozzio.   

Abstract

A protein was solubilized from the myelogenous leukemia cell line K-562 WITh 3 M KCl that specifically inhibited the antibody-dependent, complement-mediated cytolysis of 51Cr-labeled K-562 cells by a monkey antiserum to K-562. When the crude 3 M KCl extract uas fractionated with ammonium sulfate, an eightfold increase in specific activity (U inhibition/mg protein) resulted. This purified fraction migrated as a single protein band after polyacrylamide gel electrophoresis (PGE) with no detectable carbohydrate or lipid. The molecular weight of the denatured protein determined by sodium dodecyl sulfate-PGE was 77,000, similar to that of the native protein (80,000) determined by Sephadex exclusion chromatography. The protein was stable at pH 6-8, with an apparent isoelectric point between pH 5 and 6. In addition to being irreversibly denatured at pH 5 or less, it was unstable at osmolarities below 0.25 M (NaCl). It was denatured at temperatures of 56 degrees C or above. Normal human peripheral blood leukocytes were extracted similarly with 3 M KCl and fractionated with ammonium sulfate. Neither the crude preparation nor any fraction purified as described for the specific antigen inhibited the cytolytic assay, which indicated at least a quantitative lack of the protein on the surfaces of normal leukocytes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72824     DOI: 10.1093/jnci/59.6.1667

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  2 in total

1.  Relationship between the Fc receptor for IgG and the specific associated antigen of the pluripotential leukaemia cell line, K-562.

Authors:  A T Ichiki; B B Lozzio; C J Wust; C B Lozzio
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

2.  Immunotherapy of human leukemia with antibody to pluripotential K-562 stem cells.

Authors:  J Izquierdo; E R Robbio; B B Lozzio; W Hanna
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.